AVTR - Avantor, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

AVTR

AVANTOR, INC.

NYSE

$14.58

▼ DOWN 0.21% (-0.03)

KEY STATISTICS

Market Cap$9.86 B

52w High$15.93

52w Low$7.26

Dividend Yield—

Frequency—

P/E17.15

Volume5.30M

Shares Out.676.36M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Emmanuel Ligner

COMPENSATION 2026

Salary$1,140,000

Stock Awards$8,125,784

Incentive Plan Pay$1,022,795

All Other Comp.$39,355

Total$13,077,931

ABOUT

SECTOR

Healthcare

WENT PUBLIC

May 17, 2019

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

13,500

PRICE TARGET

Target High$14.00

Target Low$7.00

Target Median$10.50

Target Consensus$10.78

UPCOMING EARNINGS

DateNov 4, 2026

DayWednesday

Rev. Est.$1.64B

NOV

WED

PRICE

$14.58 ▼ DOWN 0.21% (−$0.03)

About Avantor, Inc.

https://www.avantorsciences.com ↗

Avantor, Inc. supplies biopharma, healthcare, education, and government industries worldwide with lab materials, equipment, and services, including chemicals, consumables, instrumentation, and custom solutions.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT AVANTOR, INC. IS KNOWN FOR

J.T. Baker ULTRA LC/MS Solvents

Ultra-high-purity solvents for UHPLC and mass spectrometry, essential in proteomics, drug discovery, and clinical research, ensuring accurate, reliable results by minimizing contaminants.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q3-2025	Q4-2025	Q1-2026	Q2-2026
	Proprietary Materials And Consumables	$855.6M	$869.8M ▲	$833.3M ▼	$880.4M ▲
	Third Party Materials And Consumables	$768.2M	$793.8M ▲	$748.1M ▼	$811.9M ▲

Revenue by Geography

REGION	FY2022	FY2023	FY2024	FY2025
Americas Segment	—	$4.07B	—	—
UNITED STATES	$4.28B	—	$3.55B ▼	$3.28B ▼
All Other Countries	$717.8M	—	$3.23B ▲	$3.27B ▲
Europe Segment	—	$2.42B	—	—
All Other Countries In Europe	$2.04B	—	—	—
GERMANY	$478.7M	—	—	—